You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial

Article metrics

Article menu

Download PDFPDF

Research Article
Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2023

AbstractFullPdf
Dec 2019330
Jan 2020660
Feb 2020551
Mar 202010102
Apr 2020441
May 202012125
Jun 2020880
Jul 202013132
Aug 2020111
Sep 202019193
Oct 2020661
Nov 2020662
Dec 2020552
Jan 202111112
Feb 2021332
Mar 2021440
Apr 2021660
May 2021552
Jun 202110100
Jul 2021884
Aug 202114142
Sep 202110104
Oct 2021882
Nov 2021665
Dec 202111111
Jan 202212130
Feb 2022453
Mar 2022881
Apr 202211126
May 202220200
Jun 202221221
Jul 202219202
Aug 202221210
Sep 202223232
Oct 202217172
Nov 202291110
Dec 2022880
Jan 2023880
Feb 202322231
Mar 202311124
Apr 2023673
May 2023884
Jun 2023780
Jul 202312129
Aug 202314142
Total45546694